Session » Rheumatoid Arthritis - Clinical Aspects Poster Session III
-
Abstract Number: 2584
Prediction of Disease Relapses By Multi-Biomarker Disease Test Activity in Rheumatoid Arthritis Patients Tapering DMARD Treatment
-
Abstract Number: 2585
Serum 14-3-3η Is an RA Specific Mechanistic Marker
-
Abstract Number: 2586
Cardiac Magnetic Resonance Imaging Reveals Myocardial Damage in Patients with Active Rheumatoid Arthritis
-
Abstract Number: 2587
CRP and 14-3-3η Are Each Associated with Joint Damage Progression, Their Titres Do Not Correlate and Are Better Predictors of Progression Together Than Alone
-
Abstract Number: 2588
Survivin Links Smoking and High Prevalence of Rheumatoid Arthritis in Women
-
Abstract Number: 2589
Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis
-
Abstract Number: 2590
Anti-Citrullinated Protein Antibody and Radiographic Disease Progression in Rheumatoid Arthritis
-
Abstract Number: 2591
Ultrasound Residual Synovitis Has an Impact on the Time to Relapse in RA Patients Considered in Clinical Remission: A Real Life Study of 211 Patients
-
Abstract Number: 2592
Rheumatoid Arthritis Patients with Many Autoantibodies Have Different Characteristics at Presentation Compared to Patients with Few Autoantibodies
-
Abstract Number: 2594
Multi-Biomarker Disease Activity Score As a Predictor of Flare in Patients with Rheumatoid Arthritis Who Stop TNF-Alpha-Inhibitor Therapy
-
Abstract Number: 2595
Autoantibodies to Citrullinated Fibrinogen, Anti-CCP2 and Anti-MCV Antibodies in Early Rheumatoid Arthritis Patients with Rapid Radiographic Progression at 1-Year
-
Abstract Number: 2596
Less Musculoskeletal Ultrasound Power Doppler Activity Seen in Obese Rheumatoid Arthritis
-
Abstract Number: 2597
Fine Specificity of Anti-Citrullinated Peptide Antibodies Is Associated with Left Ventricular Mass Index in Rheumatoid Arthritis Patients without Cardiovascular Disease
-
Abstract Number: 2598
Neutrophil Extracellular Trap Levels Measured By Cell Free Nucleosome ELISA in Serum Are Highly Specific and Sensitive for Rheumatoid Arthritis
-
Abstract Number: 2599
The Effect of Daily Low Dose Prednisone (divided daily versus single daily dose) in the Treatment of African Americans (AA) with Early Rheumatoid Arthritis (RA)
-
Abstract Number: 2600
Signs of Immune Activation and Local Inflammation Are Present in the Bronchial Tissue of Patients with Untreated Early Rheumatoid Arthritis
-
Abstract Number: 2601
The Multi-Biomarker Disease Activity Score in a TNF Inhibitor Tapering Study in Rheumatoid Arthritis Patients: Predictive Value for Successful Tapering, Flaring and Radiographic Progression
-
Abstract Number: 2602
CCP Antibody Negativity Is Associated with Higher Fatigue in Rheumatoid Arthritis
-
Abstract Number: 2603
What Is the Variability of HAQ over Time in Patients with Rheumatoid Arthritis Treated with Anti-TNF?
-
Abstract Number: 2604
Evaluation of Serum Undercarboxylated Osteocalcin in Premenopausal Rheumatoid Arthritis Patients; Its Correlation with Disease Activity and Bone Mineral Density
-
Abstract Number: 2605
14-3-3η Positive Status and Higher Titres Are Associated with More Severe RA
-
Abstract Number: 2606
Serum Myeloid Related Protein 8/14 Levels in Rheumatoid Arthritis: Marker of Disease Activity and Response to Methotrexate in DMARD Naïve Patients
-
Abstract Number: 2607
Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Rheumatoid Arthritis Hispanics Exposed to Biomass Smoke
-
Abstract Number: 2609
The Measurement of the Skin Autofluorescence As an Indicator of Disease Progression in Rheumatoid Arthritis Patients
-
Abstract Number: 2610
Real-World Use of Tocilizumab in Rheumatoid Arthritis Patients: Cardiovascular Risk, Concomitant Treatment, and Outcomes over 6 Months of Follow-up
-
Abstract Number: 2612
Impact of a Multibiomarker Disease Activity Score in Patients with Rheumatoid Arthritis Treated in a Real World Setting
-
Abstract Number: 2613
Patient Reported Physical Capacity Correlates with Phenylalanine Serum Levels in Patients with Early Untreated Rheumatoid Arthritis
-
Abstract Number: 2614
Single Academic Center Experience with 14-3-3 Eta in the Evaluation of Inflammatory Arthritis
-
Abstract Number: 2615
Changes in a Patient-Reported Measure of Physical Function, PF-10a, Are Most Strongly Associated with Changes in the Patient Global Assessment Portion of a Composite Measure of RA Disease Activity
-
Abstract Number: 2616
Study of Anti-Carbamylated Protein Antibody in the Rheumatoid Patients Who Were Clinically Active and Under Treatment with Biological Dmards
-
Abstract Number: 2617
Serum 14-3-3eta Protein Elevation in Osteoarthritis Suggests Misclassification or Concurrent Inflammatory Arthritis
-
Abstract Number: 2618
Methotrexate Dose May Associated with the Frequency of Lymphoproliferative Disorders in Rheumatoid Arthritis
-
Abstract Number: 2619
Clinical Usefulness of Periodic Detection of Serum 14-3-3η for Predicting Efficacy of Tocilizumab in RA
-
Abstract Number: 2620
Predictive Value of Anti-Carbamylated Protein Antibodies in Patients with Early Arthritis
-
Abstract Number: 2621
Characteristics of Histopathology and Clinical Course of 19 Cases That Developed a Lymphoproliferative Disease (LPD) during Methotrexate (MTX) Treatment.
-
Abstract Number: 2622
Serum RANKL Levels, Associate with Anti Citrullinated Proteins Antibodies (ACPA) in Early-Untreated Rheumatoid Arthritis and Is Modulated Following Methotrexate
-
Abstract Number: 2623
DAS28-ESR and DAS28-CRP Are Not Exchangeable in Daily Clinical Practice: Data from a Large Outpatient Cohort
-
Abstract Number: 2624
Preliminary Content Validation of the Patient Reported Outcomes Measurement Information System (PROMIS) Short Forms in People Living with Rheumatoid Arthritis
-
Abstract Number: 2625
SDAI 50 Is More Stringent Than the EULAR Response Measure and a Better Predictor of Low Disease State/Remission in Early Rheumatoid Arthritis: Results from an Early Arthritis Cohort
-
Abstract Number: 2626
Disease Activity Predicts ABCB1 and ABCG2 Drug-Efflux Transporters Function in Rheumatoid Arthritis (RA) Patients
-
Abstract Number: 2627
Does 14-3-3 ETA Protein Offer Any Additional Diagnostic Value in Rheumatoid Arthritis?
-
Abstract Number: 2628
Identifying Anxiety and Depression Among Rheumatoid Arthritis Patients Using the Multidimensional Health Assessment Questionnaire
-
Abstract Number: 2629
The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire
-
Abstract Number: 2630
Rheumatoid Arthritis Patients with Carotid Plaque: 10-Year Follow-up
-
Abstract Number: 2631
Rheumatologists More Likely to Perform Tobacco Cessation Counselling in Uncontrolled Rheumatoid Arthritis Visits
-
Abstract Number: 2632
Development and Validation of a Questionnaire Assessing the Fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases
-
Abstract Number: 2633
Association of Medication Beliefs, Self-Efficacy, and Adherence in a Diverse Cohort of Adults with Rheumatoid Arthritis
-
Abstract Number: 2634
Associations Between Health Literacy, Ethnicity, Communication Quality and Beliefs about Medicines in Rheumatoid Arthritis
-
Abstract Number: 2635
Validating Arthroscopic Findings Using Histology, Status for Erosive Disease, and CRP in RA
-
Abstract Number: 2636
Comparison of Arterial Health in Patients with Rheumatoid Arthritis to a Population-Based Cohort
-
Abstract Number: 2637
Prevalence of Unacceptable Pain and the Risk of Fatigue and Sleeping Problems in Early Rheumatoid Arthritis Patients
-
Abstract Number: 2638
Multiple Psychosocial Factors Influence Subjective Assessments of Disease Activity in Rheumatoid Arthritis
-
Abstract Number: 2639
Towards Patient-Centeredness of the Treat-to-Target Paradigm: Development of a Framework for Evaluation of Patients with Rheumatoid Arthritis in the Setting of Patient-Physician Discordance
-
Abstract Number: 2640
Factors Influencing Treatment Adjustments in RA Patients – Biologic DMARD Treatment Start and Options
-
Abstract Number: 2641
Correlation of Rheumatologists’ Perceptions of RA Severity with Observed Disease Activity, Patient Impact and Treatment Patterns
-
Abstract Number: 2642
Patient Reported Outcome Assessment of Rheumatoid Arthritis Patients Experience with IV Administered Biologic Therapy
-
Abstract Number: 2643
Decreased Pain Level with Aging Leads to Underestimation of Disease Activity in Rheumatoid Arthritis
-
Abstract Number: 2644
The Relationship Between Disease Activity and Cognitive Impairment in Patients with Rheumatoid Arthritis
-
Abstract Number: 2645
Changes in Clinical Disease Activity Index and Changes in Sleep Among RA Patients Initiating Disease Modifying Antirheumatic Drugs
-
Abstract Number: 2646
Different Wording of the Patient Global Assessment Scale Leads to Different Rating of Disease Activity
-
Abstract Number: 2647
Correlations Between Personality Types, Disease Activity and Quality of Life in As and RA Patients
-
Abstract Number: 2648
Vitality, Presenteeism, and Their Determinants in Patients with Early Rheumatoid Arthritis Treated with a 6-Month Induction Infliximab Therapy Added on a Triple Combination Therapy
-
Abstract Number: 2649
Test-Retest Reliability of the 5-Item Compliance Questionnaire Rheumatology and Factors Influencing Its Assessment of Adherence in Patients with Rheumatoid Arthritis
-
Abstract Number: 2650
Impact of Patient Education on the Satisfaction of Rheumatoid Arthritis Patient : A Randomized Trial of Nurse-Led Vs. Physician-Led Education
-
Abstract Number: 2651
Evaluation of the Impact of Disease-Modifying Antirheumatic Drugs on Anti-Cyclic Citrullinated Peptide Autoantibody Levels in Clinical Practice
-
Abstract Number: 2652
Power Doppler Ultrasound Features in Rheumatoid Arthritis Patients in Clinical Remission: Reclassifying Disease Activity?
-
Abstract Number: 2653
Diagnostic Value of the Prednisolone Test in Patients with Possible Rheumatoid Arthritis
-
Abstract Number: 2654
The Influence of Patient Reported Morning Stiffness on Patient Global Assessment in Rheumatoid Arthritis Patients Not Achieving ACR/EULAR Boolean Remission in a Large US Registry
-
Abstract Number: 2655
Clinically Important Worsening (CIW) of RA Disease Activity Requiring an Increase in Therapy Can be Identified Using a Combined Patient and Physician Report of Flare
-
Abstract Number: 2656
Analysis of Morning Stiffness Response in Rheumatoid Arthritis Patients with Low Disease Activity Receiving Delayed-Release Prednisone Plus Dmards As Compared to Placebo Plus Dmards
-
Abstract Number: 2657
Influence of Anxiety and Depression on the Swollen to Tender Joint Count Ratio: In Pursuit of a Phenotype of RA Patients with Somatic Complaints in a U.S. Veteran Population
-
Abstract Number: 2658
Low Disease Activity Is Associated with Higher HDL and a Trend to Lower Insulin Resistance in Rheumatoid Arthritis Patients
-
Abstract Number: 2659
Poor Correlation Between Vectra DA and DAS28 Scores in Patients with Rheumatoid Arthritis
-
Abstract Number: 2660
Elevated 14-3-3η Serum Protein Levels Increase RA Confirmation Rates in Recent-Onset Polyarthritis Patients
-
Abstract Number: 2661
Assessing Information Needs for Chronic Disease Management in Rheumatoid Arthritis
-
Abstract Number: 2662
Validation of the Quickdash in the Assessment of Rheumatoid Arthritis Disease Activity
-
Abstract Number: 2663
Evaluation of Anti-Cyclic Citrullinated Peptide Autoantibody Levels in Clinical Practice and Its Association with Disease Activity
-
Abstract Number: 2664
Flares Occur Frequently in RA Patients Undergoing Arthroplasty
-
Abstract Number: 2665
Improved Flare/ Remission Pattern in Rheumatoid Arthritis over the Recent Decades
-
Abstract Number: 2666
Trajectories of EQ-5D in RA Patients Treated with Biologics Using the IORRA Cohort
-
Abstract Number: 2667
Clinical Characteristics and Health Outcomes of RA Patients Not Adequately Controlled By Current Treatment
-
Abstract Number: 2668
Effect of Anti-Cyclic Citrullinated Peptide 2 Immunoglobulin M Serostatus on Efficacy Outcomes Following Treatment with Abatacept Plus Methotrexate
-
Abstract Number: 2669
Persistency of Patient Reported Morning (AM) Stiffness in a Large US Registry Cohort of Rheumatoid Arthritis (RA) Patients Initiating New DMARD Therapy
-
Abstract Number: 2670
Comparison of M-DAS and DAS28, Two Composite Scores for Prediction of Structural Damages in Rheumatoid Arthritis: Data from the Espoir Cohort
-
Abstract Number: 2671
Male Gender and Higher Hemoglobin Predict Response to Methotrexate in Rheumatoid Arthritis
-
Abstract Number: 2672
Determinants of Patient- Physician Discordance in Assessment of Global Disease Activity in Latinos with Rheumatoid Arthritis in the United States
-
Abstract Number: 2673
Association Between Anxiety and Depression and Rheumatoid Disease Severity: Results from an Established Rheumatoid Arthritis Cohort
-
Abstract Number: 2674
Patient Global Assessment in Evaluating Boolean-Based Remission in Rheumatoid Arthritis-Is It Really Required Instead of Physician Global Assessment? a Comparative Study with Ultrasound
-
Abstract Number: 2675
Has the Relationship Between Disease Activity and Disability in Rheumatoid Arthritis Changed?
-
Abstract Number: 2676
Is It Useful to Determine All Rheumatoid Factors Isotypes to Enhance Rheumatoid Arthritis Detection? a Clinical Laboratory Perspective
-
Abstract Number: 2677
Targeting Biomarkers of Nitric Oxide and Endothelial Dysfunction in Patients with Rheumatoid Arthritis
-
Abstract Number: 2678
Vitamin D Serum Level in Early Arthritis Patients: Association with Disease Activity, Disability and Severity in the Espoir Cohort
-
Abstract Number: 2679
Development and Validation of a HAQ-Derived Tool to Detect Muscle Mass Deficits in Rheumatoid Arthritis
-
Abstract Number: 2680
Severity of Morning Stiffness Is Associated More Strongly with Disease Activity in Patients with Rheumatoid Arthritis
-
Abstract Number: 2681
Physical Function, Sleep, Depression but Not CRP Level Is Associated with Fatigue in Patients with Established Rheumatoid Arthritis
-
Abstract Number: 2682
A Brief Patient-Reported Measure of Physical Function Is Sensitive to Changes in a Composite Disease Activity Measure in a Diverse Rheumatoid Arthritis Clinic Setting
-
Abstract Number: 2683
Contribution of Subjective Patient Reported Components of Disease Activity Scores Differs in Disease Activity Measures and Their Changes over Time Are Closely Associated with Objective Measures
-
Abstract Number: 2684
Association Between Anxiety and Depression and Rheumatoid Arthritis Outcome: Results from an Inception Early Rheumatoid Arthritis Cohort
-
Abstract Number: 2685
High Levels of 25(OH)D Are Associated with Lower Disease Activity in Patients with Newly Diagnosed Rheumatoid Arthritis
-
Abstract Number: 2686
No Clear Association Between the Presence of Ultrasound Synovitis and Patient Reported Outcomes in Rheumatoid Arthritis Patients in Remission
-
Abstract Number: 2687
Clinical Significance of Patient-Reported Pain and Stiffness at Each Joint Level in the Evaluation of Patients with Rheumatoid Arthritis
-
Abstract Number: 2688
Socioeconomic Status, Ethnicity/Race, and Autoantibody Status in Rheumatoid Arthritis
-
Abstract Number: 2689
Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity Are Multifactorial in Early Rheumatoid Arthritis
-
Abstract Number: 2691
Musculoskeletal Ultrasound in Multi-Center Rheumatoid Arthritis Clinical Trials: Methodology for Optimizing Reliability of Acquisition and Real-Time Scoring
-
Abstract Number: 2693
Comparing Eight Year Clinical and Radiographic Outcome in Two Cohorts of Patients with Rheumatoid Arthritis
-
Abstract Number: 2694
Variations in the Metabolome in Response to Disease Activity of Rheumatoid Arthritis
-
Abstract Number: 2695
Th17 Cell Related Cytokines and Microarray Expression Profiles in Patients with Early Rheumatoid Arthritis